Design of engineered vaccines for systemic and mucosal immunity to HIV

Pathologie Biologie

Volumn 49, Issue 6, 2001, Pages 466-467

  Berzofsky, J A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HIV; Mucosal immunity; Peptides; T lymphocytes; Vaccine

Indexed keywords

CYTOKINE; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY;

CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MUCOSAL IMMUNITY; VACCINATION; VACCINE PRODUCTION;

EID: 0034940083     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(01)00167-5     Document Type: Conference Paper

References (1)

1. Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections